{"id":71436,"date":"2026-05-20T11:25:00","date_gmt":"2026-05-20T11:25:00","guid":{"rendered":"https:\/\/medsbase.com\/hcg-peptide\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"hcg-peptide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/hcg-peptide\/","title":{"rendered":"HCG (Human Chorionic Gonadotropin) \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is HCG (pharmaceutical-grade)?<\/h3>\n<p style=\"margin: 0;\"><strong>HCG<\/strong> (Gonadotrofina Cori\u00f4nica Humana) \u00e9 um horm\u00f4nio glicoproteico composto por duas subunidades n\u00e3o covalentemente associadas (\u03b1, 92 amino\u00e1cidos \u2014 compartilhada com LH\/FSH\/TSH; \u03b2, 145 amino\u00e1cidos \u2014 exclusiva do HCG), com peso molecular combinado aproximado de ~36,7 kDa. \u00c9 a ferramenta farmacol\u00f3gica can\u00f4nica para ativar o <strong>receptor LH\/CG (LHCGR)<\/strong> on Leydig cells (driving testosterone production in male study models) and ovarian theca \/ granulosa cells (driving follicular maturation and ovulation in female reproductive studies). The pharmaceutical-grade material supplied here is the urinary-extracted glycoform (CAS 9002-61-3) at \u226599% HPLC purity, lyophilized in 5,000 IU or 10,000 IU vials. It is <em>funcionalmente distinto<\/em> from the recombinant rHCG (choriogonadotropin alfa, CAS 56832-30-5) used in some clinical preparations. Supplied ready for use.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Classe do Composto<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Horm\u00f4nio glicoproteico heterodim\u00e9rico (subunidades \u03b1 + \u03b2); agonista do receptor LH\/CG (LHCGR); horm\u00f4nio pept\u00eddico<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nome Qu\u00edmico<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gonadotrofina Cori\u00f4nica Humana (glicoforma extra\u00edda da urina; uHCG)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">9002-61-3 (HCG urin\u00e1rio); 56832-30-5 (coriogonadotrofina alfa recombinante \u2014 n\u00e3o \u00e9 a forma fornecida aqui)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Estrutura das Subunidades<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Heterod\u00edmero de duas subunidades associadas n\u00e3o covalentemente: subunidade \u03b1 (92 amino\u00e1cidos, compartilhada com LH\/FSH\/TSH) e subunidade \u03b2 (145 amino\u00e1cidos, exclusiva do HCG). Ambas as subunidades s\u00e3o extensamente N- e O-glicosiladas \u2014 o alto conte\u00fado de \u00e1cido si\u00e1lico da subunidade \u03b2 \u00e9 respons\u00e1vel pela meia-vida plasm\u00e1tica excepcionalmente longa do HCG em rela\u00e7\u00e3o ao LH.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~36.700 Da (~36,7 kDa) heterod\u00edmero combinado; subunidade \u03b1 ~14 kDa, subunidade \u03b2 ~22 kDa (altamente glicosilada)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Glicoprote\u00edna heterodim\u00e9rica \u2014 subunidade \u03b1 (92 aa, compartilhada com LH\/FSH\/TSH) + subunidade \u03b2 (145 aa, espec\u00edfica do hCG). A alta sialila\u00e7\u00e3o (~30% p\/p de carboidratos) confere meia-vida plasm\u00e1tica de 33\u201337 h. N\u00e3o h\u00e1 uma \u00fanica f\u00f3rmula molecular devido \u00e0 composi\u00e7\u00e3o vari\u00e1vel de glicoformas; peso molecular apenas da prote\u00edna ~25 kDa, totalmente glicosilado ~36,7 kDa.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Mecanismo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liga-se e ativa o receptor de LH\/CG (<strong>LHCGR<\/strong>) \u2014 um GPCR acoplado a Gs expresso em c\u00e9lulas de Leydig (test\u00edculo) e c\u00e9lulas da teca ovariana\/granulosa. A ativa\u00e7\u00e3o do receptor estimula a adenilato ciclase, aumenta o cAMP intracelular, ativa a PKA e induz as enzimas esteroidog\u00eanicas (StAR, CYP17A1, CYP11A1) que impulsionam a bioss\u00edntese de novo de testosterona (masculino) ou estrog\u00eanio\/progesterona (feminino). HCG e LH compartilham o mesmo receptor e a mesma cascata de sinaliza\u00e7\u00e3o.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Convers\u00e3o UI-para-mg<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~9.300 UI por mg de material altamente purificado (refer\u00eancia do 5\u00ba Padr\u00e3o Internacional da OMS). Portanto, 1 UI equivale a aproximadamente 108 ng do pept\u00eddeo puro. Um frasco de 5.000 UI cont\u00e9m ~0,54 mg do pept\u00eddeo; um frasco de 10.000 UI cont\u00e9m ~1,08 mg.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Elimina\u00e7\u00e3o bif\u00e1sica \u2014 fase inicial ~6 h, fase terminal 33\u201337 h. Substancialmente mais longa que a do LH (~20 min) \u2014 devido ao alto teor de \u00e1cido si\u00e1lico nos glicanos da subunidade \u03b2, que reduz a depura\u00e7\u00e3o hep\u00e1tica.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white amorphous powder; single-use vials. Supplied with a separate stopper-sealed lyophilized cake (no in-vial diluent).<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC); bioensaio da OMS confirma pot\u00eancia de liga\u00e7\u00e3o ao LHCGR consistente com o 5\u00ba Padr\u00e3o Internacional. COA dispon\u00edvel sob solicita\u00e7\u00e3o.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Reconstitute in bacteriostatic water (the standard supply diluent) at 1.0 mL per 5,000 IU (\u2192 5,000 IU\/mL working stock) or 2.0 mL per 10,000 IU (\u2192 5,000 IU\/mL); other dilutions per protocol. Mannitol-based lyophilization cake dissolves rapidly with gentle swirling \u2014 do not shake. Avoid vortexing (high-shear can dissociate the \u03b1\/\u03b2 heterodimer).<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C fechado para estoque de trabalho de curto prazo; \u221220 \u00b0C para armazenamento de longo prazo (est\u00e1vel \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). Reconstitu\u00eddo: 2\u20138 \u00b0C, use dentro de ~30 dias. Proteja da luz. <strong>N\u00e3o congele o material reconstitu\u00eddo<\/strong> \u2014 ciclos de congelamento-descongelamento dissociam o heterod\u00edmero \u03b1\/\u03b2 e destroem a bioatividade.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 HCG?<\/h2>\n<p><strong>HCG<\/strong> (Human Chorionic Gonadotropin, CAS 9002-61-3) is a glycoprotein peptide hormone in the same gonadotropin family as luteinising hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). Like the other three, it is a heterodimer of an \u03b1-subunit (92 amino acids, identical across all four hormones) and a \u03b2-subunit (145 amino acids, unique to HCG). The \u03b1 and \u03b2 subunits are non-covalently associated and both are extensively glycosylated \u2014 the \u03b2-subunit alone carries four N-linked and four O-linked glycans, and the high sialic-acid content of these glycans is responsible for HCG&#8217;s exceptionally long plasma half-life relative to LH (33\u201337 h terminal, versus ~20 min for LH). Endogenous HCG is produced by the syncytiotrophoblast of the developing placenta during pregnancy, where it maintains the corpus luteum and progesterone production for the first ~10 weeks of gestation. Outside pregnancy it is not normally present at detectable levels; its appearance in serum or urine is therefore the basis of pregnancy testing. The pharmacological utility of HCG in studies, however, has nothing to do with this physiological role and everything to do with the fact that HCG binds and activates the same LH\/CG receptor (LHCGR) as endogenous LH \u2014 but with far longer duration of action. HCG is therefore the standard pharmacological tool for sustained LHCGR activation in studies that probes Leydig-cell function, gonadal steroidogenesis, spermatogenesis, follicular development, ovulation, and the HPG axis broadly. Two molecular forms of HCG exist in commerce: the urinary-extracted form (<strong>uHCG<\/strong>, CAS 9002-61-3), purificada da urina de mulheres gr\u00e1vidas, que \u00e9 o que fornecemos; e a forma recombinante (<strong>rHCG<\/strong> ou coriogonadotrofina alfa, CAS 56832-30-5), produzida em c\u00e9lulas CHO e usada em algumas prepara\u00e7\u00f5es cl\u00ednicas (Ovidrel \/ Ovitrelle). As duas formas t\u00eam a mesma sequ\u00eancia de amino\u00e1cidos e o mesmo perfil de liga\u00e7\u00e3o ao LHCGR, mas os padr\u00f5es de glicosila\u00e7\u00e3o diferem ligeiramente entre a extra\u00e7\u00e3o urin\u00e1ria e a express\u00e3o em c\u00e9lulas CHO \u2014 compara\u00e7\u00f5es de bioensaio publicadas relatam uma pot\u00eancia in vivo amplamente equivalente. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Ativa\u00e7\u00e3o do Receptor LH\/CG e Esteroidog\u00eanese<\/h2>\n<p>O mecanismo do HCG est\u00e1 entre os mais caracterizados na farmacologia end\u00f3crina:<\/p>\n<ul>\n<li><strong>Liga\u00e7\u00e3o ao receptor LH\/CG (LHCGR)<\/strong> \u2014 O HCG se liga ao LHCGR (um GPCR acoplado a G\u03b1s da classe A com um grande dom\u00ednio extracelular rico em leucina), com alta afinidade e no mesmo s\u00edtio de liga\u00e7\u00e3o que o LH end\u00f3geno. A distribui\u00e7\u00e3o do receptor \u00e9 restrita ao tecido gonadal: c\u00e9lulas de Leydig do test\u00edculo (homens) e c\u00e9lulas da teca ovariana, c\u00e9lulas da granulosa mural e c\u00e9lulas da granulosa luteinizadas (mulheres). O LHCGR tamb\u00e9m \u00e9 expresso em n\u00edveis mais baixos nas c\u00e9lulas do corpo l\u00fateo, onde o HCG sustenta a produ\u00e7\u00e3o de progesterona no in\u00edcio da gravidez.<\/li>\n<li><strong>Cascata de sinaliza\u00e7\u00e3o Gs-cAMP-PKA<\/strong> \u2014 O LHCGR ativado se acopla ao G\u03b1s, elevando o AMP c\u00edclico intracelular, ativando a PKA e impulsionando a fosforila\u00e7\u00e3o do CREB e outros fatores de transcri\u00e7\u00e3o a jusante. O cAMP tamb\u00e9m envolve o EPAC para alguns efeitos a jusante. A ativa\u00e7\u00e3o da PKA em c\u00e9lulas esteroidog\u00eanicas especificamente regula positivamente a prote\u00edna StAR (prote\u00edna regulat\u00f3ria aguda esteroidog\u00eanica), que transporta o colesterol atrav\u00e9s da membrana externa mitocondrial \u2014 o passo limitante da esteroidog\u00eanese de novo.<\/li>\n<li><strong>Indu\u00e7\u00e3o de enzimas esteroidog\u00eanicas<\/strong> \u2014 A ativa\u00e7\u00e3o sustentada do LHCGR pelo HCG impulsiona a regula\u00e7\u00e3o transcricional da cascata de enzimas esteroidog\u00eanicas: CYP11A1 (clivagem da cadeia lateral do colesterol), CYP17A1 (17\u03b1-hidroxilase \/ 17,20-liase), 3\u03b2-HSD e 17\u03b2-HSD. O resultado l\u00edquido nas c\u00e9lulas de Leydig \u00e9 a bioss\u00edntese sustentada de testosterona de novo; nas c\u00e9lulas tecais ovarianas, a mesma cascata produz androstenediona (que as c\u00e9lulas da granulosa convertem em estradiol via CYP19A1 \/ aromatase sob estimula\u00e7\u00e3o do FSH).<\/li>\n<li><strong>Dura\u00e7\u00e3o funcional e taquifilaxia<\/strong> \u2014 A single HCG bolus produces sustained LHCGR activation lasting 5\u20137 days in study models, because of HCG&#8217;s long plasma half-life (33\u201337 h) and the LHCGR&#8217;s slow internalization kinetics. Repeated high-dose HCG dosing can produce LHCGR desensitization (tachyphylaxis) \u2014 a well-documented phenomenon in published Leydig-cell studies that is relevant to chronic-dosing protocols.<\/li>\n<li><strong>Feedback hipot\u00e1lamo-hipofis\u00e1rio<\/strong> \u2014 Like endogenous testosterone, HCG-driven testosterone output feeds back to the hypothalamus and pituitary to suppress GnRH and LH\/FSH secretion. In the context of suppressed-HPG studies (testosterone replacement, AAS exposure, or pharmacological HPG suppression), HCG bypasses the hypothalamic-pituitary blockade by acting directly at the Leydig-cell LHCGR \u2014 which is why HCG is the canonical tool for probing Leydig-cell preserved function under HPG suppression.<\/li>\n<\/ul>\n<p>HCG and LH activate the same receptor through the same cascade, but with two key practical differences: HCG produces longer, more sustained signalling per dose (because of its longer half-life), and HCG is administered exogenously while endogenous LH is pulsatile and centrally regulated. Study protocols that need sustained, controllable LHCGR activation use HCG; protocols that need pulsatile, physiological LHCGR activation use recombinant LH or GnRH-driven endogenous LH. <\/p>\n<h2>Published Evidence<\/h2>\n<p>HCG is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia do LHCGR \u2014 o agonista de refer\u00eancia can\u00f4nico<\/strong> \u2014 de longe o ativador do receptor LH\/CG mais citado na literatura publicada; composto padr\u00e3o para estudos de cin\u00e9tica de internaliza\u00e7\u00e3o do receptor, estudos de vi\u00e9s de sinaliza\u00e7\u00e3o e desenvolvimento de novos moduladores de pequenas mol\u00e9culas direcionados ao LHCGR<\/li>\n<li><strong>Biologia das c\u00e9lulas de Leydig e esteroidog\u00eanese gonadal<\/strong> \u2014 HCG is the standard pharmacological stimulus for de-novo testosterone biosynthesis in primary Leydig-cell culture and ex-vivo testicular slice preparations; widely used in studies on Leydig-cell function, mitochondrial cholesterol transport, StAR regulation, and steroidogenic-enzyme cascade kinetics<\/li>\n<li><strong>HPG-axis suppression-recovery<\/strong> \u2014 in study models where endogenous LH\/FSH has been suppressed (by exogenous testosterone administration, anabolic-androgenic-steroid exposure, or pharmacological GnRH antagonism), HCG acts directly at the Leydig-cell LHCGR to maintain testosterone output and preserve Leydig-cell function; the canonical tool for dissecting the HPG-axis suppression-recovery dynamics<\/li>\n<li><strong>Spermatogenesis studies<\/strong> \u2014 used in combination with FSH or FSH-analogues in published Sertoli-cell \/ spermatogonial-stem-cell studies; sustains the high-intratesticular-testosterone microenvironment required for spermatogenesis even in the face of suppressed circulating LH<\/li>\n<li><strong>Ovarian follicular development and ovulation studies<\/strong> \u2014 in female reproductive studies, HCG is used to mimic the LH surge that triggers final follicular maturation, oocyte meiotic resumption, and follicular rupture; standard tool in published ovulation-trigger protocols, oocyte-maturation studies, and luteinization studies<\/li>\n<li><strong>Biologia do corpo l\u00fateo<\/strong> \u2014 HCG sustains corpus-luteum function and progesterone production by direct LHCGR activation on luteal cells; used in published studies on the luteal phase and the luteo-placental transition<\/li>\n<li><strong>Farmacologia de receptores e agonismo tendencioso<\/strong> \u2014 o LHCGR exibe sinaliza\u00e7\u00e3o tendenciosa de cAMP versus arrestina, e o HCG \u00e9 o agonista total de refer\u00eancia contra o qual ligantes tendenciosos (pequenas mol\u00e9culas moduladoras alost\u00e9ricas do LHCGR, ORG-43553 e outros) s\u00e3o comparados<\/li>\n<li><strong>Farmacologia comparativa versus LH e coriogonadotropina alfa recombinante<\/strong> \u2014 published studies has compared urinary-extracted HCG (uHCG, what we supply), recombinant HCG (rHCG \/ choriogonadotropin alfa), and recombinant LH (Luveris) head-to-head for receptor-binding, cAMP signalling, and in-vivo testosterone-output endpoints<\/li>\n<\/ul>\n<p>For broader context on HPG-axis and reproductive-system peptides in this catalogue, see <a href=\"https:\/\/medsbase.com\/pt-br\/kisspeptin-10\/\">Kisspeptina-10<\/a> (o regulador hipotal\u00e2mico upstream do GnRH \u2014 o complemento pept\u00eddico mais direto do eixo HPG para o HCG), <a href=\"https:\/\/medsbase.com\/pt-br\/pt-141\/\">PT-141 (Bremelanotide)<\/a> (melanocortin receptor pharmacology \u2014 sexual-function studies), <a href=\"https:\/\/medsbase.com\/pt-br\/oxytocin-acetate\/\">Acetato de Ocitocina<\/a> (the hypothalamic posterior-pituitary peptide hormone \u2014 reproductive \/ social bonding), and <a href=\"https:\/\/medsbase.com\/pt-br\/tesamorelin\/\">Tesamorelina<\/a> (an\u00e1logo do GHRH \u2014 um eixo end\u00f3crino diferente, mas comumente coestudado). Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>Concentra\u00e7\u00f5es e Dosagens Dispon\u00edveis<\/h2>\n<p>MedsBase stocks HCG (urinary-extracted glycoform) in two lyophilized vial sizes calibrated to typical protocol dose ranges. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosagem do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos de Embalagem<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5.000 UI<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 single-dose Leydig-cell stimulation, individual-animal HPG-suppression-recovery protocols, ovulation-trigger studies (HCG 5,000 IU is the historical canonical ovulation-induction dose); in-vitro receptor pharmacology at known IU-to-receptor stoichiometry<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10.000 UI<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-strength vial \u2014 extended-dosing protocols, multi-animal cohort work, high-dose Leydig-cell stimulation studies, multi-week chronic dosing studies; lowest per-IU cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical entity (lyophilized urinary-extracted HCG, \u226599% HPLC purity, WHO 5th International Standard bioassay-confirmed potency). The 10,000 IU vial provides the lowest per-IU cost for large-cohort or chronic-dosing studies; the 5,000 IU vial is convenient for single-dose stimulation experiments or smaller-cohort work where vial-to-vial dosing accuracy matters more than per-IU cost. Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>Como Comparar \u2014 HCG vs Kisspeptina-10<\/h2>\n<p>HCG e <a href=\"https:\/\/medsbase.com\/pt-br\/kisspeptin-10\/\">Kisspeptina-10<\/a> s\u00e3o as duas ferramentas pept\u00eddicas do eixo HPG neste cat\u00e1logo, e elas atuam em camadas completamente diferentes do mesmo eixo. O HCG age <em>a jusante<\/em>, no receptor LH\/CG das c\u00e9lulas de Leydig\/c\u00e9lulas da teca, imitando diretamente o pico de LH \u2014 \u00fatil quando o objetivo \u00e9 impulsionar a esteroidog\u00eanese das c\u00e9lulas de Leydig ou induzir a ovula\u00e7\u00e3o, independentemente do estado HPG a montante. A Kisspeptina-10 age <em>a montante<\/em>, at hypothalamic Kiss1R-expressing GnRH neurons, mimicking the kisspeptin signal that drives endogenous pulsatile GnRH and downstream LH\/FSH release \u2014 useful when the goal is to interrogate the physiological HPG-axis cascade end-to-end. The two compounds are mechanistically complementary, and protocols sometimes combine them to dissect upstream-hypothalamic vs downstream-gonadal contributions to reproductive endocrine output. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HCG<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kisspeptina-10<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe qu\u00edmica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Horm\u00f4nio glicoproteico heterodim\u00e9rico (subunidades \u03b1 + \u03b2, ~244 aa no total, altamente glicosilado)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pept\u00eddeo linear de 10 res\u00edduos (o fragmento C-terminal bioativo da kisspeptina-54 completa)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~36,7 kDa<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1.302 Da<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Receptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Receptor de LH\/CG (LHCGR, GPCR acoplado a Gs) em c\u00e9lulas de Leydig\/t\u00e9ca\/granulosa<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kiss1R (GPR54, GPCR acoplado a Gq) em neur\u00f4nios hipotal\u00e2micos de GnRH<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Ponto de interven\u00e7\u00e3o no eixo HPG<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">A jusante \u2014 gonadal (contorna completamente hipot\u00e1lamo e hip\u00f3fise)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">A montante \u2014 hipotal\u00e2mico (aciona a cascata fisiol\u00f3gica GnRH \u2192 LH\/FSH \u2192 esteroides gonadais)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fun\u00e7\u00e3o das c\u00e9lulas de Leydig, esteroidog\u00eanese gonadal, recupera\u00e7\u00e3o da supress\u00e3o HPG, desencadeamento da ovula\u00e7\u00e3o, biologia do corpo l\u00fateo, farmacologia do LHCGR<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GnRH-neuron biology, HPG-axis integration, puberty \/ fertility studies, hypothalamic kisspeptin \/ NKB \/ dynorphin network<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Longo \u2014 terminal de 33\u201337 h (dirigido por sialila\u00e7\u00e3o)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Curto \u2014 minutos (pequeno pept\u00eddeo, sem glicoprote\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">500\u20135.000 IU SC\/IM em roedores (dose \u00fanica); 250\u2013500 IU\/dia em protocolos cr\u00f4nicos<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u2013100 \u00b5g SC em roedores; administra\u00e7\u00e3o puls\u00e1til em protocolos cr\u00f4nicos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Status WADA<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Proibido em todos os momentos para atletas masculinos (S2 \u2014 Horm\u00f4nios Pept\u00eddicos); isen\u00e7\u00e3o para atletas femininas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Atualmente n\u00e3o est\u00e1 na Lista de Subst\u00e2ncias Proibidas da WADA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on direct gonadal-cell steroidogenesis, ovulation triggering, or downstream LHCGR pharmacology, HCG is the canonical reference compound. For studies focused on hypothalamic GnRH-neuron biology, HPG-axis integration, or upstream reproductive-endocrine signalling, <a href=\"https:\/\/medsbase.com\/pt-br\/kisspeptin-10\/\">Kisspeptina-10<\/a> \u00e9 a ferramenta mais direcionada. Veja tamb\u00e9m <a href=\"https:\/\/medsbase.com\/pt-br\/pt-141\/\">PT-141 (Bremelanotide)<\/a> for melanocortin-receptor pharmacology and sexual-function studies, and <a href=\"https:\/\/medsbase.com\/pt-br\/oxytocin-acetate\/\">Acetato de Ocitocina<\/a> for posterior-pituitary peptide-hormone studies. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Precisa de \u00e1gua BAC?<\/strong> A reconstitui\u00e7\u00e3o de qualquer frasco liofilizado requer \u00e1gua bacteriost\u00e1tica est\u00e9ril. Combine este produto com nosso <a href=\"\/pt-br\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 frasco multidose de 30 mL, preservado com 0,9% de \u00e1lcool benz\u00edlico, grau USP.<\/div>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para estoque de trabalho de curto prazo. Para armazenamento de longo prazo, congele frascos fechados a \u221220 \u00b0C (est\u00e1vel \u226536 meses a \u221220 \u00b0C; \u226518 meses a 2\u20138 \u00b0C). O HCG liofilizado \u00e9 razoavelmente est\u00e1vel porque as subunidades \u03b1 e \u03b2 s\u00e3o mantidas juntas por intera\u00e7\u00f5es hidrof\u00f3bicas e liga\u00e7\u00f5es de hidrog\u00eanio que n\u00e3o s\u00e3o rompidas no estado liofilizado, mas a prote\u00edna \u00e9 sens\u00edvel \u00e0 exposi\u00e7\u00e3o \u00e0 umidade e ao ciclo t\u00e9rmico. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> para o frasco de 5.000 IU, injete 1,0 mL de \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o comprimido liofilizado) \u2014 isso resulta em um estoque de trabalho de 5.000 IU\/mL. Para o frasco de 10.000 IU, injete 2,0 mL de \u00e1gua bacteriost\u00e1tica para o mesmo estoque de trabalho de 5.000 IU\/mL, ou 1,0 mL para um estoque de alta concentra\u00e7\u00e3o de 10.000 IU\/mL. <strong>Agite suavemente para dissolver \u2014 n\u00e3o agite vigorosamente, n\u00e3o use v\u00f3rtex.<\/strong> A mistura de alta cisalhamento dissocia o heterod\u00edmero \u03b1\/\u03b2 e destr\u00f3i a bioatividade de liga\u00e7\u00e3o ao LHCGR. O comprimido liofilizado \u00e0 base de manitol geralmente se dissolve em 30\u201360 segundos com agita\u00e7\u00e3o suave. <strong>Regras cr\u00edticas de armazenamento para material reconstitu\u00eddo:<\/strong> uma vez reconstitu\u00eddo, armazene a 2\u20138 \u00b0C e use dentro de 30 dias. <strong>N\u00e3o congele o HCG reconstitu\u00eddo<\/strong> \u2014 freeze-thaw cycles dissociate the heterodimer and irreversibly destroy bioactivity. Protect from light. Discard if cloudiness, particulates, or marked colour change appears. For protocols that require multiple aliquots, prepare the aliquots at the time of reconstitution and store them at 2\u20138 \u00b0C separately rather than freezing \u2014 short-term refrigerated storage retains bioactivity better than even single freeze-thaw cycles. <\/p>\n<h2>Perguntas Frequentes<\/h2>\n<h3>Qual \u00e9 a diferen\u00e7a entre o HCG extra\u00eddo da urina (uHCG) e o HCG recombinante (rHCG \/ coriogonadotropina alfa)?<\/h3>\n<p><strong>HCG extra\u00eddo da urina<\/strong> (o que fornecemos, CAS 9002-61-3) \u00e9 purificado da urina coletada de mulheres gr\u00e1vidas usando cromatografia de troca i\u00f4nica e filtra\u00e7\u00e3o em gel. <strong>HCG recombinante<\/strong> (coriogonadotropina alfa, CAS 56832-30-5; prepara\u00e7\u00f5es cl\u00ednicas Ovidrel \/ Ovitrelle) \u00e9 produzido em c\u00e9lulas CHO a partir de cDNAs clonados das subunidades \u03b1 e \u03b2 do HCG. As duas formas t\u00eam a mesma sequ\u00eancia de amino\u00e1cidos e se ligam ao LHCGR com a mesma afinidade, mas os padr\u00f5es de glicosila\u00e7\u00e3o diferem ligeiramente entre o material derivado da urina e o expresso em c\u00e9lulas CHO. Compara\u00e7\u00f5es bioqu\u00edmicas publicadas relatam pot\u00eancia in vivo amplamente equivalente, com o rHCG mostrando padr\u00f5es de glicosila\u00e7\u00e3o mais consistentes entre lotes e o uHCG apresentando um conte\u00fado de \u00e1cido si\u00e1lico ligeiramente maior, t\u00edpico da glicosila\u00e7\u00e3o placent\u00e1ria. <\/p>\n<h3>Quantas UI equivalem a 1 mg de HCG?<\/h3>\n<p>O material de refer\u00eancia do 5\u00ba Padr\u00e3o Internacional da OMS define a pot\u00eancia do HCG em aproximadamente 9.300 UI por mg de pept\u00eddeo puro. Praticamente: um frasco de 5.000 UI cont\u00e9m ~0,54 mg de pept\u00eddeo; um frasco de 10.000 UI cont\u00e9m ~1,08 mg. A UI \u00e9 uma unidade definida por bioensaio que reflete a pot\u00eancia de liga\u00e7\u00e3o ao LHCGR em vez de massa, e a raz\u00e3o UI\/mg varia ligeiramente entre glicoformas e entre lotes \u2014 por isso o HCG farmac\u00eautico \u00e9 rotulado em UI em vez de mg. <\/p>\n<h3>What published dose ranges have been used in rodent studies?<\/h3>\n<p>Single-bolus rodent protocols typically use 50\u2013250 IU SC or IM for cAMP \/ receptor-internalization studies, and 500\u20135,000 IU SC for sustained testosterone-output protocols (3\u20137 day duration of action per bolus). Chronic protocols use 100\u2013500 IU\/day for 2\u20134 weeks. The published ovulation-trigger dose in rodents is typically 5\u201310 IU per mouse or 10\u201350 IU per rat IP. In-vitro Leydig-cell stimulation protocols typically use 0.1\u201310 IU\/mL in culture medium. Users should consult primary literature appropriate to the species, model, and endpoint of interest. <\/p>\n<h3>Por que o HCG tem uma meia-vida muito mais longa que o LH?<\/h3>\n<p>A subunidade \u03b2 do HCG carrega quatro glicanos ligados a N e quatro glicanos ligados a O, com um conte\u00fado excepcionalmente alto de \u00e1cido si\u00e1lico (NeuAc) nas posi\u00e7\u00f5es terminais desses glicanos. O receptor de asialoglicoprote\u00edna (ASGR) nos hepat\u00f3citos \u00e9 a principal via pela qual os horm\u00f4nios da fam\u00edlia das gonadotropinas s\u00e3o eliminados da circula\u00e7\u00e3o \u2014 o ASGR reconhece res\u00edduos terminais de galactose \/ N-acetilgalactosamina expostos ap\u00f3s a remo\u00e7\u00e3o de \u00e1cido si\u00e1lico terminal por sialidase. Como a subunidade \u03b2 do HCG \u00e9 t\u00e3o intensamente e terminalmente sialilada, a depura\u00e7\u00e3o mediada pelo ASGR hep\u00e1tico \u00e9 muito mais lenta do que para a subunidade \u03b2 do LH, que \u00e9 menos sialilada, produzindo a dram\u00e1tica diferen\u00e7a de meia-vida (HCG 33\u201337 h vs LH ~20 min). <\/p>\n<h3>Por que o HCG reconstitu\u00eddo n\u00e3o pode ser congelado?<\/h3>\n<p>O HCG \u00e9 um heterod\u00edmero de duas subunidades associadas n\u00e3o covalentemente. A intera\u00e7\u00e3o \u03b1\/\u03b2 \u00e9 est\u00e1vel no liofilizado (porque n\u00e3o h\u00e1 \u00e1gua para as subunidades se separarem) e est\u00e1vel em solu\u00e7\u00e3o aquosa refrigerada a 2\u20138 \u00b0C (porque a cin\u00e9tica de dissocia\u00e7\u00e3o \u00e9 lenta em baixa temperatura). Mas a forma\u00e7\u00e3o de cristais de gelo durante o congelamento separa fisicamente as subunidades, e uma vez dissociadas, elas se reassociam de forma ineficiente ap\u00f3s o descongelamento. O resultado \u00e9 que o HCG congelado e descongelado ret\u00e9m uma grande fra\u00e7\u00e3o de imunorreatividade (a subunidade \u03b2 ainda \u00e9 detect\u00e1vel por anticorpo), mas perde uma grande fra\u00e7\u00e3o de bioatividade (as subunidades dissociadas n\u00e3o engajam produtivamente o LHCGR). O HCG liofilizado pode ser congelado e \u00e9 est\u00e1vel a \u221220 \u00b0C; o HCG reconstitu\u00eddo n\u00e3o pode. <\/p>\n<h3>Qual \u00e9 o status regulat\u00f3rio da HCG pela WADA?<\/h3>\n<p>A HCG est\u00e1 na Lista de Subst\u00e2ncias Proibidas da Ag\u00eancia Mundial Antidoping (WADA) na classe S2 (Horm\u00f4nios Pept\u00eddicos, Fatores de Crescimento, Subst\u00e2ncias Relacionadas e Mim\u00e9ticos). \u00c9 proibida em todos os momentos \u2014 tanto durante competi\u00e7\u00f5es quanto fora delas \u2014 para <strong>atletas do sexo masculino apenas<\/strong>. Female athletes are exempt because HCG is a natural pregnancy hormone and therefore detectable in any pregnant woman regardless of administration. Users conducting human-subject studies with HCG need to be aware of this regulatory status. For clinical in-vitro and rodent in-vivo studies the WADA status is informational only. <\/p>\n<h3>Can HCG be combined with Kisspeptin-10, FSH, or testosterone in protocols?<\/h3>\n<p>Yes \u2014 these compounds target different layers of the HPG axis (upstream, mid, downstream) and are commonly combined in studies that aims to dissect axis integration. The most-published combinations are HCG with FSH (or FSH analogues) for spermatogenesis or follicular-development studies; HCG with <a href=\"https:\/\/medsbase.com\/pt-br\/kisspeptin-10\/\">Kisspeptina-10<\/a> for upstream-vs-downstream dissection; HCG with exogenous testosterone (for HPG-suppression-recovery, where the testosterone suppresses LH and HCG bypasses the suppression). Reconstitute each separately and follow each compound&#8217;s specific storage rules \u2014 HCG in particular must not be frozen reconstituted (see above). <\/p>\n<h3>How does this pharmaceutical-grade HCG compare with the branded clinical preparations (Eutrig, HUCOG, ZyHCG, Pregnyl, Ovidrel)?<\/h3>\n<p>The branded clinical preparations are urinary-extracted HCG (Eutrig HP, HUCOG, ZyHCG, Pregnyl) or recombinant HCG (Ovidrel \/ Ovitrelle) packaged under various manufacturer SKUs for clinical use in fertility and reproductive medicine. The pharmaceutical-grade HCG supplied here is the same urinary-extracted glycoform (uHCG, CAS 9002-61-3) at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use HCG should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro receptor pharmacology, rodent in-vivo work, or other clinical applications can use the material supplied here. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for HPG-Axis and Reproductive Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-br\/kisspeptin-10\/\"><strong>Kisspeptina-10<\/strong><\/a> \u2014 Agonista Kiss1R hipotal\u00e2mico \u2014 regulador do eixo HPG a montante, estimula a pulsatileidade do GnRH<\/li>\n<li><a href=\"\/pt-br\/pt-141\/\"><strong>PT-141 (Bremelanotide)<\/strong><\/a> \u2014 Melanocortin-4 receptor agonist \u2014 sexual-function studies<\/li>\n<li><a href=\"\/pt-br\/oxytocin-acetate\/\"><strong>Acetato de Ocitocina<\/strong><\/a> \u2014 Posterior pituitary nonapeptide \u2014 reproductive and social bonding<\/li>\n<li><a href=\"\/pt-br\/tesamorelin\/\"><strong>Tesamorelina<\/strong><\/a> \u2014 An\u00e1logo do GHRH \u2014 eixo end\u00f3crino diferente, comumente coestudado<\/li>\n<li><a href=\"\/pt-br\/sermorelin\/\"><strong>Sermorelina<\/strong><\/a> \u2014 GHRH 1-29 analogue \u2014 pituitary GH-axis studies<\/li>\n<li><a href=\"\/pt-br\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 Necess\u00e1rio para reconstituir qualquer frasco liofilizado \u2014 diluente est\u00e9ril, preservado com 0,9% de \u00e1lcool benz\u00edlico<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Glicoprote\u00edna heterodim\u00e9rica \u2014 subunidade \u03b1 + \u03b2 (~244 aa, ~36.7 kDa)<br \/>\n\u2705 Agonista can\u00f4nico do receptor LH\/CG (LHCGR) \u2014 estimula a esteroidog\u00eanese em c\u00e9lulas de Leydig<br \/>\n\u2705 Meia-vida plasm\u00e1tica longa (33\u201337 h) vs LH (~20 min) \u2014 mediada por \u00e1cido si\u00e1lico<br \/>\n\u2705 Glicoforma extra\u00edda da urina (uHCG, CAS 9002-61-3), \u226599% HPLC, bioensaio padr\u00e3o OMS 5\u00aa IS<br \/>\n\u2705 For clinical studies only \u2014 distinct from branded clinical preparations<\/p>\n<p><strong>HCG (Pharmaceutical Grade)<\/strong> cont\u00e9m Gonadotrofina Cori\u00f4nica Humana extra\u00edda da urina.<\/p>","protected":false},"featured_media":71445,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6490,3826,6492,5663,6491,6493,6494],"class_list":["post-71436","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-gonadotropin","product_tag-hcg","product_tag-hpg-axis","product_tag-human-chorionic-gonadotropin","product_tag-lhcgr-agonist","product_tag-reproductive-research","product_tag-research-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/71436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=71436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/71445"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=71436"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=71436"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=71436"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=71436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}